Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Largest borrow rate increases among liquid names » 08:45
03/05/20
03/05
08:45
03/05/20
08:45
GME

GameStop

$3.76 /

+0.13 (+3.58%)

, HEXO

Hexo

$1.24 /

+0.115 (+10.27%)

, FTR

Frontier Communications

$0.51 /

-0.023 (-4.32%)

, XLB

S&P Select Materials SPDR

$56.77 /

+2.24 (+4.11%)

, CHWY

Chewy

$27.91 /

+0.135 (+0.49%)

, CGC

Canopy Growth

$17.75 /

+0.42 (+2.42%)

, PBYI

Puma Biotechnology

$11.50 /

+1.08 (+10.36%)

, AVDL

Avadel Pharmaceuticals

$10.20 /

+0.01 (+0.10%)

, FCAU

Fiat Chrysler

$12.40 /

+0.4 (+3.33%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: GameStop (GME) 62.56% +2.46, Hexo Corp (HEXO) 70.27% +0.83, Frontier Communications (FTR) 98.82% +0.80, Materials Sector SPDR ETF (XLB) 0.89% +0.51, Chewy (CHWY) 0.77% +0.29, Canopy Growth (CGC) 53.59% +0.24, KraneShares China Internet (KWEB) 1.27% +0.21, Puma Biotechnology (PBYI) 0.48% +0.14, Avadel Pharmaceuticals (AVDL) 11.62% +0.11, and Fiat Chrysler (FCAU) 0.75% +0.10.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cowen to hold a conference » 04:55
03/04/20
03/04
04:55
03/04/20
04:55
A

Agilent

$80.44 /

-1.54 (-1.88%)

, ABBV

AbbVie

$87.57 /

-1.03 (-1.16%)

, ADRO

Aduro Biotech

$3.04 /

+ (+0.00%)

, ALXN

Alexion

$93.85 /

-2.08 (-2.17%)

, BBIO

BridgeBio

$32.37 /

+0.17 (+0.53%)

, CTMX

CytomX Therapeutics

$7.28 /

+0.18 (+2.54%)

, EPZM

Epizyme

$20.71 /

-2.33 (-10.11%)

, FOMX

Foamix

$3.35 /

-0.095 (-2.76%)

, IMGN

ImmunoGen

$4.39 /

-0.02 (-0.45%)

, LLY

Eli Lilly

$130.32 /

-2.24 (-1.69%)

, MORF

Morphic Holding

$15.78 /

-0.18 (-1.13%)

, MSON

Misonix

$13.87 /

+0.01 (+0.07%)

, JNJ

Johnson & Johnson

$135.71 /

-4.28 (-3.06%)

, HZNP

Horizon Therapeutics

$34.39 /

-0.72 (-2.05%)

, GILD

Gilead

$74.26 /

-1.14 (-1.51%)

, EW

Edwards Lifesciences

$209.03 /

-3.4 (-1.60%)

, DVAX

Dynavax

$4.25 /

-0.23 (-5.13%)

, BSX

Boston Scientific

$37.22 /

-1.01 (-2.64%)

, BMRN

BioMarin

$92.66 /

-1.81 (-1.92%)

, BLUE

Bluebird Bio

$71.14 /

-2.75 (-3.72%)

, BIIB

Biogen

$315.79 /

-12.18 (-3.71%)

, CERS

Cerus

$5.02 /

-0.08 (-1.57%)

, HARP

Harpoon Therapeutics

$15.70 /

-0.56 (-3.44%)

, IRWD

Ironwood

$12.24 /

-0.44 (-3.47%)

, JAZZ

Jazz Pharmaceuticals

$115.32 /

-9.64 (-7.71%)

, MRNA

Moderna

$27.91 /

-1.965 (-6.58%)

, ZTS

Zoetis

$137.33 /

-1.56 (-1.12%)

, XOMA

Xoma

$24.48 /

-0.52 (-2.08%)

, TECH

Bio-Techne

$193.46 /

-3.94 (-2.00%)

, TMO

Thermo Fisher

$310.46 /

+5.76 (+1.89%)

, SEEL

Seelos Therapeutics

$0.87 /

-0.0238 (-2.67%)

, PIRS

Pieris Pharmaceuticals

$3.16 /

-0.13 (-3.95%)

, PFE

Pfizer

$34.27 /

-0.62 (-1.78%)

, PBYI

Puma Biotechnology

$10.42 /

-0.25 (-2.34%)

, NLTX

Neoleukin Therapeutics

$10.59 /

-0.03 (-0.28%)

, OXFD

Oxford Immunotec

$13.21 /

-0.1 (-0.75%)

, RYTM

Rhythm Pharmaceuticals

$19.59 /

-0.83 (-4.06%)

40th Annual Healthcare…

40th Annual Healthcare Conference will be held in Boston on March 2-4.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cowen to hold a conference » 04:55
03/03/20
03/03
04:55
03/03/20
04:55
A

Agilent

$81.98 /

+4.4 (+5.67%)

, ABBV

AbbVie

$88.60 /

+3.265 (+3.83%)

, ADRO

Aduro Biotech

$3.04 /

+0.09 (+3.05%)

, ALXN

Alexion

$95.93 /

+3.8 (+4.12%)

, BBIO

BridgeBio

$32.20 /

+1.71 (+5.61%)

, CTMX

CytomX Therapeutics

$7.10 /

-0.02 (-0.28%)

, EPZM

Epizyme

$23.04 /

+2.57 (+12.55%)

, FOMX

Foamix

$3.45 /

-0.09 (-2.55%)

, IMGN

ImmunoGen

$4.41 /

+0.02 (+0.46%)

, LLY

Eli Lilly

$132.56 /

+6.1 (+4.82%)

, MORF

Morphic Holding

$15.96 /

+0.28 (+1.79%)

, MSON

Misonix

$13.86 /

-0.48 (-3.35%)

, JNJ

Johnson & Johnson

$139.99 /

+1.03 (+0.74%)

, HZNP

Horizon Therapeutics

$35.11 /

+1.08 (+3.17%)

, GILD

Gilead

$75.40 /

+2.74 (+3.77%)

, EW

Edwards Lifesciences

$212.43 /

-0.63 (-0.30%)

, DVAX

Dynavax

$4.48 /

+0.52 (+13.13%)

, BSX

Boston Scientific

$38.23 /

+0.34 (+0.90%)

, BMRN

BioMarin

$94.47 /

+4.61 (+5.13%)

, BLUE

Bluebird Bio

$73.89 /

+6.79 (+10.12%)

, BIIB

Biogen

$327.97 /

+18.1 (+5.84%)

, CERS

Cerus

$5.10 /

-0.07 (-1.35%)

, HARP

Harpoon Therapeutics

$16.26 /

+2.01 (+14.11%)

, IRWD

Ironwood

$12.68 /

+0.775 (+6.51%)

, JAZZ

Jazz Pharmaceuticals

$124.96 /

+11.835 (+10.46%)

, MRNA

Moderna

$29.87 /

+3.71 (+14.18%)

, ZTS

Zoetis

$138.89 /

+4.94 (+3.69%)

, XOMA

Xoma

$25.00 /

+1.32 (+5.57%)

, TECH

Bio-Techne

$197.40 /

+3.82 (+1.97%)

, TMO

Thermo Fisher

$304.70 /

+6.54 (+2.19%)

, SEEL

Seelos Therapeutics

$0.89 /

+0.05 (+5.95%)

, PIRS

Pieris Pharmaceuticals

$3.29 /

+0.15 (+4.78%)

, PFE

Pfizer

$34.89 /

+0.77 (+2.26%)

, PBYI

Puma Biotechnology

$10.67 /

+0.65 (+6.49%)

, NLTX

Neoleukin Therapeutics

$10.62 /

+0.47 (+4.63%)

, OXFD

Oxford Immunotec

$13.31 /

-0.19 (-1.41%)

, RYTM

Rhythm Pharmaceuticals

$20.42 /

+2.27 (+12.51%)

40th Annual Healthcare…

40th Annual Healthcare Conference will be held in Boston on March 2-4.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cowen to hold a conference » 08:00
03/02/20
03/02
08:00
03/02/20
08:00
A

Agilent

$76.99 /

-0.59 (-0.76%)

, ABBV

AbbVie

$85.27 /

-0.065 (-0.08%)

, ADRO

Aduro Biotech

$3.06 /

+0.11 (+3.73%)

, ALXN

Alexion

$93.69 /

+1.56 (+1.69%)

, BBIO

BridgeBio

$31.75 /

+1.26 (+4.13%)

, CTMX

CytomX Therapeutics

$6.73 /

-0.39 (-5.48%)

, EPZM

Epizyme

$21.41 /

+0.94 (+4.59%)

, FOMX

Foamix

$3.61 /

+0.075 (+2.12%)

, IMGN

ImmunoGen

$4.44 /

+0.05 (+1.14%)

, LLY

Eli Lilly

$126.31 /

-2.955 (-2.29%)

, MORF

Morphic Holding

$15.80 /

+0.12 (+0.77%)

, MSON

Misonix

$13.91 /

-0.43 (-3.00%)

, JNJ

Johnson & Johnson

$134.35 /

-4.61 (-3.32%)

, HZNP

Horizon Therapeutics

$34.24 /

+0.21 (+0.62%)

, GILD

Gilead

$69.37 /

-3.29 (-4.53%)

, EW

Edwards Lifesciences

$204.43 /

-8.63 (-4.05%)

, DVAX

Dynavax

$3.95 /

-0.11 (-2.71%)

, BSX

Boston Scientific

$37.35 /

-0.54 (-1.43%)

, BMRN

BioMarin

$90.34 /

+0.48 (+0.53%)

, BLUE

Bluebird Bio

$72.38 /

+5.28 (+7.87%)

, BIIB

Biogen

$308.58 /

-1.29 (-0.42%)

, CERS

Cerus

$5.12 /

-0.05 (-0.97%)

, HARP

Harpoon Therapeutics

$15.19 /

+0.94 (+6.60%)

, IRWD

Ironwood

$12.04 /

+0.135 (+1.13%)

, JAZZ

Jazz Pharmaceuticals

$114.98 /

+1.86 (+1.64%)

, MRNA

Moderna

$25.93 /

-0.23 (-0.88%)

, ZTS

Zoetis

$133.07 /

-0.88 (-0.66%)

, XOMA

Xoma

$24.00 /

+0.32 (+1.35%)

, TECH

Bio-Techne

$189.07 /

-4.51 (-2.33%)

, TMO

Thermo Fisher

$290.75 /

-7.41 (-2.49%)

, SEEL

Seelos Therapeutics

$0.87 /

+0.0342 (+4.07%)

, PIRS

Pieris Pharmaceuticals

$3.11 /

-0.03 (-0.96%)

, PFE

Pfizer

$33.44 /

-0.68 (-1.99%)

, PBYI

Puma Biotechnology

$10.76 /

+0.74 (+7.39%)

, NLTX

Neoleukin Therapeutics

$9.83 /

-0.32 (-3.15%)

, OXFD

Oxford Immunotec

$13.19 /

-0.31 (-2.30%)

, RYTM

Rhythm Pharmaceuticals

$18.97 /

+0.82 (+4.52%)

40th Annual Healthcare…

40th Annual Healthcare Conference will be held in Boston on March 2-4.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Hot Stocks
Puma Biotechnology announces FDA approval of neratinib with capecitabine sNDA » 08:13
02/26/20
02/26
08:13
02/26/20
08:13
PBYI

Puma Biotechnology

$11.31 /

-1.25 (-9.95%)

Puma Biotechnology…

Puma Biotechnology announced that the FDA approved a supplemental new drug application, or sNDA, for neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. The sNDA approval was based on results of the Phase III NALA trial, a randomized controlled trial of neratinib plus capecitabine in patients with HER2-positive metastatic breast cancer who have received two or more prior anti-HER2-based regimens.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 19:03
02/20/20
02/20
19:03
02/20/20
19:03
EHTH

eHealth

$129.11 /

-2.99 (-2.26%)

, AERI

Aerie Pharmaceuticals

$19.95 /

+0.49 (+2.52%)

, ZIXI

Zix

$8.00 /

+0.28 (+3.63%)

, BAND

Bandwidth

$76.20 /

+0.18 (+0.24%)

, DBX

Dropbox

$18.70 /

+0.39 (+2.13%)

, NCMI

National CineMedia

$7.99 /

+0.045 (+0.57%)

, TXRH

Texas Roadhouse

$66.37 /

+1.37 (+2.11%)

, SFM

Sprouts Farmers Market

$16.05 /

+0.185 (+1.17%)

, GLOB

Globant

$125.75 /

-3.45 (-2.67%)

, SSRM

SSR Mining

$18.66 /

-0.09 (-0.48%)

, PRA

ProAssurance

$32.34 /

-0.405 (-1.24%)

, CATM

Cardtronics

$42.09 /

-0.57 (-1.34%)

, SBAC

SBA Communications

$291.98 /

+2.16 (+0.75%)

, FND

Floor & Decor

$54.87 /

+1.37 (+2.56%)

, BXRX

Baudax Bio

$7.95 /

+0.1 (+1.27%)

, S

Sprint

$9.52 /

+0.02 (+0.21%)

, TRUE

TrueCar

$3.94 /

+0.14 (+3.68%)

, FSLR

First Solar

$59.31 /

+1.98 (+3.45%)

, LTHM

Livent

$11.87 /

+0.44 (+3.85%)

, ZS

Zscaler

$65.23 /

-0.01 (-0.02%)

, APPN

Appian

$62.55 /

+0.35 (+0.56%)

, CNDT

Conduent

$4.97 /

+0.24 (+5.07%)

, BOOM

DMC Global

$39.30 /

-0.005 (-0.01%)

, PBYI

Puma Biotechnology

$13.91 /

-0.05 (-0.36%)

, BLDR

Builders FirstSource

$28.17 /

+0.17 (+0.61%)

, FSLY

Fastly

$24.59 /

+0.375 (+1.55%)

, BYD

Boyd Gaming

$34.74 /

+0.635 (+1.86%)

, ENV

Envestnet

$86.40 /

+0.2 (+0.23%)

, CUBE

CubeSmart

$31.63 /

+0.22 (+0.70%)

, BJRI

BJ's Restaurants

$43.68 /

+0.59 (+1.37%)

, ROG

Rogers Corporation

$110.25 /

-1.15 (-1.03%)

, COG

Cabot Oil & Gas

$15.34 /

-0.26 (-1.67%)

, OLED

Universal Display

$178.64 /

-0.22 (-0.12%)

, OEC

Orion Engineered

$17.05 /

+0.555 (+3.36%)

, NBR

Nabors Industries

$2.34 /

+0.075 (+3.32%)

, CVA

Covanta

$15.63 /

+0.01 (+0.06%)

, VICI

VICI Properties

$28.12 /

+0.655 (+2.38%)

, ASPN

Aspen Aerogels

$10.60 /

+0.48 (+4.74%)

, FIT

Fitbit

$6.46 /

-0.01 (-0.15%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: eHealth (EHTH) up 17.7%... Aeri Pharma (AERI) up 15.1%... Zix Corp (ZIXI) up 11.9%... Bandwidth (BAND) up 11.7%... Drobox (DBX) up 10.9%... National CineMedia (NCMI) up 8.0%... Texas Roadhouse (TXRH) up 7.2%... Sprouts Farmers (SFM) up 6.1%... Globant (GLOB) up 5.1%... SSR Mining (SSRM) up 4.4%... Pro Assurance (PRA) up 3.2%... Cardtronics (CATM) up 2.4%... SBA Communications (SBAC) up 1.9%... Floor&Decor (FND) up 1.4%. ALSO HIGHER: Baudax Bio (BXRX) up 21.5% after FDA approval of Anjeso for pain management... Sprint (S) up 5.2% after modifying T-Mobile combination closing as early as Apr. 1st. DOWN AFTER EARNINGS: TrueCar (TRUE) down 23.5%... First Solar (FSLR) down 13.7%... Livent Corp (LTHM) down 13.2%... Zscaler (ZS) down 12.3%... Appian Corp (APPN) down 10.6%... Conduent (CNDT) down 9.7%... DMC Global (BOOM) down 9.7%... Puma Biotechnology (PBYI) down 8.1%... Builders FirstSource (BLDR) down 7.7%... Fastly (FSLY) down 5.7%... Boyd Gaming (BYD) down 5.0%... Envestnet (ENV) down 4.3%... CubeSmart (CUBE) down 4.1%... BJ's Restaurants (BJRI) down 3.9%... Rogers Corp (ROG) down 3.9%... Cabot Oil (COG) down 3.8%... Universal Displays (OLED) down 2.9%... Orion Engineered Carbons (OEC) down 2.6%... Nabors (NBR) down 2.6%... Covanta Holding (CVA) down 2.4%... Vici Properties (VICI) down 1.9%... Aspen Aerogels (ASPN) down 1.6%... Fitbit (FIT) down 1.2%. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Puma Biotechnology reports Q4 adjusted EPS 1c, consensus (48c) » 16:08
02/20/20
02/20
16:08
02/20/20
16:08
PBYI

Puma Biotechnology

$14.10 /

+0.14 (+1.00%)

Reports Q4 revenue…

Reports Q4 revenue $62.9M, cocnsensus $59.96M. "During 2019, Puma made broad strides to increase global commercial access to NERLYNX by HER2-positive breast cancer patients, as well as to expand the label and potential therapeutic indications of NERLYNX," said Alan H. Auerbach, Chairman, Chief Executive Officer and President of Puma. "Our year concluded with a label expansion to address NERLYNX side effects, registration approval in Hong Kong and marketing approval in Singapore for NERLYNX, an expanded license agreement with Pierre Fabre, as well as several clinical data presentations at SABCS. We believe these regulatory, commercial, partnering and clinical milestones position Puma for improved results in 2020 and beyond."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cantor specialty pharma analyst to hold an analyst/industry conference call » 09:25
01/27/20
01/27
09:25
01/27/20
09:25
IMMU

Immunomedics

$18.30 /

-0.24 (-1.29%)

, SGEN

Seattle Genetics

$113.63 /

-1.69 (-1.47%)

, MGNX

MacroGenics

$10.80 /

-0.6 (-5.26%)

, PBYI

Puma Biotechnology

$8.10 /

-0.72 (-8.16%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, ARVN

Arvinas

$50.06 /

-0.78 (-1.53%)

Large Cap & Specialty…

Large Cap & Specialty Pharmaceuticals Analyst Chen, along with Key Opinion Leader Timothy Pluard, Medical Director of Saint Luke's Cancer Institute, discuss the 2020 outlook in breast cancer and potential approvals in TNBC (Triple-Negative Breast Cancer) and HER2+ (Human Epidermal Growth Factor Receptor 2) on an Analyst/Industry conference call to be held on January 27 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cantor specialty pharma analyst to hold an analyst/industry conference call » 04:55
01/27/20
01/27
04:55
01/27/20
04:55
IMMU

Immunomedics

$18.30 /

-0.24 (-1.29%)

, SGEN

Seattle Genetics

$113.63 /

-1.69 (-1.47%)

, MGNX

MacroGenics

$10.80 /

-0.6 (-5.26%)

, PBYI

Puma Biotechnology

$8.10 /

-0.72 (-8.16%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, ARVN

Arvinas

$50.06 /

-0.78 (-1.53%)

Large Cap & Specialty…

Large Cap & Specialty Pharmaceuticals Analyst Chen, along with Key Opinion Leader Timothy Pluard, Medical Director of Saint Luke's Cancer Institute, discuss the 2020 outlook in breast cancer and potential approvals in TNBC (Triple-Negative Breast Cancer) and HER2+ (Human Epidermal Growth Factor Receptor 2) on an Analyst/Industry conference call to be held on January 27 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cantor specialty pharma analyst to hold an analyst/industry conference call » 09:01
01/21/20
01/21
09:01
01/21/20
09:01
IMMU

Immunomedics

$19.01 /

-0.3 (-1.55%)

, SGEN

Seattle Genetics

$108.99 /

+1.33 (+1.24%)

, MGNX

MacroGenics

$11.27 /

-0.34 (-2.93%)

, PBYI

Puma Biotechnology

$9.72 /

+0.83 (+9.34%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, ARVN

Arvinas

$50.96 /

-0.29 (-0.57%)

Large Cap & Specialty…

Large Cap & Specialty Pharmaceuticals Analyst Chen, along with Key Opinion Leader Timothy Pluard, Medical Director of Saint Luke's Cancer Institute, discuss the 2020 outlook in breast cancer and potential approvals in TNBC (Triple-Negative Breast Cancer) and HER2+ (Human Epidermal Growth Factor Receptor 2) on an Analyst/Industry conference call to be held on January 27 at 11 am.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.